ICP-105
/ InnoCare
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
July 06, 2022
Study of ICP-105 in Solid Tumors Patients
(clinicaltrials.gov)
- P1 | N=21 | Completed | Sponsor: Beijing InnoCare Pharma Tech Co., Ltd. | Recruiting ➔ Completed | N=54 ➔ 21
Enrollment change • Trial completion • Oncology • Solid Tumor
August 18, 2021
Study of ICP-105 in Solid Tumors Patients
(clinicaltrials.gov)
- P1; N=54; Recruiting; Sponsor: Beijing InnoCare Pharma Tech Co., Ltd.; Trial completion date: Jul 2021 ➔ Dec 2022; Trial primary completion date: Dec 2020 ➔ Dec 2022
Clinical • Trial completion date • Trial primary completion date • Oncology • Solid Tumor
1 to 2
Of
2
Go to page
1